Novel Plasmid-Mediated tet (X5) Gene Conferring Resistance to Tigecycline, Eravacycline, and Omadacycline in a Clinical Acinetobacter baumannii Isolate-Reference-Cited by-同舟云学术

Novel Plasmid-Mediated tet (X5) Gene Conferring Resistance to Tigecycline, Eravacycline, and Omadacycline in a Clinical Acinetobacter baumannii Isolate

Published:2019-12-20 Issue:1 Volume:64 Page:
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Wang Liyuan¹,Liu Dejun²,Lv Yuan¹,Cui Lanqing¹,Li Yun¹,Li Tianmeng¹,Song Huangwei²,Hao Yuxin²,Shen Jianzhong²,Wang Yang²,Walsh Timothy R.²³

Affiliation:

1. Institute of Clinical Pharmacology, Peking University First Hospital, Beijing, China

2. Beijing Advanced Innovation Center for Food Nutrition and Human Health, College of Veterinary Medicine, China Agricultural University, Beijing, China

3. Department of Medical Microbiology and Infectious Disease, Institute of Infection and Immunity, Cardiff, United Kingdom

Abstract

A novel, plasmid-mediated, high-level tigecycline resistance tet (X) gene variant, tet (X5), was detected in a clinical Acinetobacter baumannii isolate from China in 2017. Tet(X5) shows 84.5% and 90.5% amino acid identity to Tet(X3) and Tet(X4), respectively, with similar binding sites and a comparable affinity for tetracyclines. The tet (X5)-containing plasmid could only be transferred to A. baumannii via electrotransformation.

Funder

Medical Research Council grants DETER-XDRE-CHINA

National Natural Science Foundation of China

MOST | National Key Research and Development Program of China Stem Cell and Translational Research

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.01326-19

Reference13 articles.

1. Efficacy and safety of tigecycline for the treatment of infectious diseases: a meta-analysis

2. Carbapenem-Resistant Acinetobacter baumannii and Enterobacteriaceae in South and Southeast Asia

3. Emergence of plasmid-mediated high-level tigecycline resistance genes in animals and humans

4. European Committee on Antimicrobial Susceptibility Testing. 2019. Breakpoint tables for interpretation of MICs and zone diameters. Version 9.0 2019. http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Breakpoint_tables/v_9.0_Breakpoint_Tables.pdf.

5. Clinical and Laboratory Standards Institute. 2019. Performance standards for antimicrobial susceptibility testing. CLSI M100-S29. Clinical and Laboratory Standards Institute, Wayne, PA.

Cited by 131 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence and genomic characterization of clinical Escherichia coli strains that harbor the plasmid-borne tet(X4) gene in China;Microbiological Research;2024-08

2. Identification of novel Tet(X6)-Tet(X2) recombinant variant in Elizabethkingia meningoseptica from a bullfrog farm and downstream river in China;Frontiers in Microbiology;2024-07-31

3. Clinical and microbiological features of a cohort of patients with Acinetobacter baumannii bloodstream infections;European Journal of Clinical Microbiology & Infectious Diseases;2024-07-18

4. Nosocomial transmission of tet(x3), blaNDM-1 and blaOXA-97-carrying Acinetobacter baumannii conferring resistance to eravacycline and omadacycline, the Netherlands, March to August 2021;Eurosurveillance;2024-07-11

5. Current and novel therapies for management of Acinetobacter baumannii -associated pneumonia;Critical Reviews in Microbiology;2024-07